Research suggests that the JAK2/STAT3 pathway is involved in B7-H4-mediated IL-6 secretion in esophageal squamous cell carcinoma (ESCC) cells and enhances the growth and tumorigenicity of cells [42]. Here, VTCN1 is linked to esophageal squamous cell carcinoma.